Nimodipine: Recall – Crystallization of Fill Material

by FDA on September 5, 2012

in MedWatch

The product may no longer be bioequivalent and may potentially affect patients who are being treated for a medical emergency.

This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.

View Full Details Of The Original MedWatch Notice Here.

Bookmark and Share

Leave a Comment

Previous post:

Next post: